CRISPR Therapeutics proved the strength of its technology a couple of years ago when it won approval for its first product.

Intellia Therapeutics said its Crispr-based treatment for hereditary angioedema met its goals in a Phase 3 trial, marking a ...

A CRISPR Therapy Just Cured A Disease From Inside The Body For The First Time. The Gene-Editing Era Officially Started Monday ...

JMIR Publications today featured two new stories in its News and Perspectives section, highlighting a shift toward proactive, ...

Intellia Therapeutics, a leading biotechnology company, announced that its CRISPR-based treatment for a rare swelling ...

Researchers have used modified CRISPR to silence the extra chromosome 21 in Down syndrome cells, showing promising ...

Following its FDA-approved Casgevy therapy for sickle cell disease and beta thalassemia, CRISPR technology is now being tested in autoimmune disorders and early Down syndrome studies. CRISPR ...

As the spread of infectious diseases accelerates, technologies that can accurately distinguish multiple viruses in a single test are becoming ...

Toronto, April 30, 2026) JMIR Publications today featured two new stories in its News and Perspectives section, highlighting a shift toward ...

As the spread of infectious diseases accelerates, technologies that can accurately distinguish multiple viruses in a single ...

Intellia Therapeutics has reported the first-ever phase 3 results with an in vivo gene-editing therapy, hereditary angioedema ...

The cultivar is giving the industry renewed confidence in the future, said Florida Citrus Mutual Board President Kevin ...